Renal Effect Seen In Neupro Lab Values, But Not Robust Enough For Label
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Data supporting an FDA safety reviewer's concerns that laboratory value changes seen in Neupro studies could indicate an effect on renal function were found insufficiently robust for inclusion in labeling by supervisory reviewers, FDA documents show